Research and Markets (http://www.researchandmarkets.com/research/9qlp2q/cancer) has announced the addition of the "Cancer Diagnostics 2020: Supplier Shares, Country Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review" report to their offering.

This new report is based on a new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Worldwide Market Overview:

  • Five-year test volume and sales projections by country.
  • Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.
  • Estimated universe of laboratories performing cancer diagnostic testing by country.
  • Cancer statistics, etiology and recent developments in the U.S., Europe, and Asia.

Instrumentation Review:

  • Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.
  • Technology Assessment:
  • Assessment of latest technologies and their potential applications for cancer diagnostic testing.
  • Review of competing/complementing technologies.
  • Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies:

  • Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

Companies Analyzed:

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca BioPharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics/Theradiag
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Thermo Fisher
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zilla

Contains 1,200 pages and 450 tables

For more information visit http://www.researchandmarkets.com/research/9qlp2q/cancer